211 related articles for article (PubMed ID: 15648796)
1. C-reactive protein and erythrocyte sedimentation rate in patients with heterotopic ossification after spinal cord injury.
Estrores IM; Harrington A; Banovac K
J Spinal Cord Med; 2004; 27(5):434-7. PubMed ID: 15648796
[TBL] [Abstract][Full Text] [Related]
2. Heterotopic ossification mimicking infection in patients with traumatic spinal cord injury.
Citak M; Grasmücke D; Salber J; Cruciger O; Meindl R; Schildhauer TA; Aach M
Technol Health Care; 2016; 24(1):87-91. PubMed ID: 26409557
[TBL] [Abstract][Full Text] [Related]
3. Prevention and treatment of heterotopic ossification after spinal cord injury.
Banovac K; Sherman AL; Estores IM; Banovac F
J Spinal Cord Med; 2004; 27(4):376-82. PubMed ID: 15484668
[TBL] [Abstract][Full Text] [Related]
4. Evaluation and management of heterotopic ossification in patients with spinal cord injury.
Banovac K; Gonzalez F
Spinal Cord; 1997 Mar; 35(3):158-62. PubMed ID: 9076866
[TBL] [Abstract][Full Text] [Related]
5. The effect of etidronate on late development of heterotopic ossification after spinal cord injury.
Banovac K
J Spinal Cord Med; 2000; 23(1):40-4. PubMed ID: 10752873
[TBL] [Abstract][Full Text] [Related]
6. Intravenous disodium etidronate therapy in spinal cord injury patients with heterotopic ossification.
Banovac K; Gonzalez F; Wade N; Bowker JJ
Paraplegia; 1993 Oct; 31(10):660-6. PubMed ID: 8259329
[TBL] [Abstract][Full Text] [Related]
7. Use of nonsteroidal anti-inflammatory drugs to prevent heterotopic ossification after spinal cord injury: a retrospective chart review.
Zakrasek EC; Yurkiewicz SM; Dirlikov B; Pence BT; Crew JD
Spinal Cord; 2019 Mar; 57(3):214-220. PubMed ID: 30254206
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory sacroiliitis in a man with spinal cord injury.
Duman I; Taskaynatan MA; Ozgul A; Dincer K
J Spinal Cord Med; 2008; 31(3):312-4. PubMed ID: 18795484
[TBL] [Abstract][Full Text] [Related]
9. Treatment of heterotopic ossification after spinal cord injury.
Banovac K; Gonzalez F; Renfree KJ
J Spinal Cord Med; 1997 Jan; 20(1):60-5. PubMed ID: 9097258
[TBL] [Abstract][Full Text] [Related]
10. Association between alendronate, serum alkaline phosphatase level, and heterotopic ossification in individuals with spinal cord injury.
Ploumis A; Donovan JM; Olurinde MO; Clark DM; Wu JC; Sohn DJ; O'Connor KC
J Spinal Cord Med; 2015 Mar; 38(2):193-8. PubMed ID: 24820653
[TBL] [Abstract][Full Text] [Related]
11. The roles of serum alkaline and bone alkaline phosphatase levels in predicting heterotopic ossification following spinal cord injury.
Citak M; Grasmücke D; Suero EM; Cruciger O; Meindl R; Schildhauer TA; Aach M
Spinal Cord; 2016 May; 54(5):368-70. PubMed ID: 26643987
[TBL] [Abstract][Full Text] [Related]
12. The value of serum creatine kinase in early diagnosis of heterotopic ossification.
Sherman AL; Williams J; Patrick L; Banovac K
J Spinal Cord Med; 2003; 26(3):227-30. PubMed ID: 14997963
[TBL] [Abstract][Full Text] [Related]
13. Agreement between erythrocyte sedimentation rate and C-reactive protein in hospital practice.
Colombet I; Pouchot J; Kronz V; Hanras X; Capron L; Durieux P; Wyplosz B
Am J Med; 2010 Sep; 123(9):863.e7-13. PubMed ID: 20800157
[TBL] [Abstract][Full Text] [Related]
14. Neurogenic heterotopic ossification in spinal cord injury.
van Kuijk AA; Geurts AC; van Kuppevelt HJ
Spinal Cord; 2002 Jul; 40(7):313-26. PubMed ID: 12080459
[TBL] [Abstract][Full Text] [Related]
15. Development of heterotopic ossifications, blood markers and outcome after radiation therapy in spinal cord injured patients.
Krauss H; Maier D; Bühren V; Högel F
Spinal Cord; 2015 May; 53(5):345-8. PubMed ID: 25420497
[TBL] [Abstract][Full Text] [Related]
16. The treatment of immature heterotopic ossification in spinal cord injury with combination surgery, radiation therapy and NSAID.
Freebourn TM; Barber DB; Able AC
Spinal Cord; 1999 Jan; 37(1):50-3. PubMed ID: 10025696
[TBL] [Abstract][Full Text] [Related]
17. Refractory heterotopic ossification with complications.
Yin KS; James J; Lew K; Little JW
J Spinal Cord Med; 2001; 24(2):119-22. PubMed ID: 11587419
[TBL] [Abstract][Full Text] [Related]
18. Early diagnosis of heterotopic ossification among patients admitted to a neurological Post-Intensive Care Rehabilitation Unit.
Carpentier VT; Salga M; Gatin L; Genêt F; Paquereau J
Eur J Phys Rehabil Med; 2021 Aug; 57(4):527-534. PubMed ID: 33448758
[TBL] [Abstract][Full Text] [Related]
19. Serum alkaline phosphatase and inorganic phosphorus values in spinal cord injury patients with heterotopic ossification.
Kim SW; Charter RA; Chai CJ; Kim SK; Kim ES
Paraplegia; 1990 Sep; 28(7):441-7. PubMed ID: 2123534
[TBL] [Abstract][Full Text] [Related]
20. Prevention of heterotopic ossification after spinal cord injury with COX-2 selective inhibitor (rofecoxib).
Banovac K; Williams JM; Patrick LD; Levi A
Spinal Cord; 2004 Dec; 42(12):707-10. PubMed ID: 15179440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
